Sign in
Mitchell

Mitchell

Research Analyst at H.C. Wainwright

New York, NY, US

Mitchell Kapoor is an Analyst at H.C. Wainwright, specializing in the general sector with primary coverage concentrated in the U.S. market. He has issued analyst ratings on companies such as LEGN, HALO, and TYRA, and has made over 371 stock recommendations, with approximately 29% yielding profitable outcomes and an average return of -21.4% per rating, ranking #9,361 out of 9,436 Wall Street analysts on TipRanks. Kapoor began issuing public analyst ratings in 2023; details on prior employers or more comprehensive career history are not publicly available. Professional credentials such as FINRA registration and securities licenses have not been specifically disclosed in accessible public profiles.

Mitchell's questions to Ultragenyx Pharmaceutical (RARE) leadership

Question · Q3 2025

Mitchell asked about the rationale behind the recent Crysvita transaction and whether there's a threshold for monetizing mature products to recycle capital into the pipeline versus retaining recurring income.

Answer

Erik Harris, Chief Commercial Officer, explained that the company sought the most efficient cost of capital, finding excellent valuation for the Crysvita royalty. Howard Horn, Chief Financial Officer, added that the competitive process aimed for meaningful proceeds, low cost of capital, and maximized cash preservation, with the payment holiday being beneficial. He noted that monetizing future-dated revenues now bolsters the balance sheet for upcoming launches and growth.

Ask follow-up questions

Fintool

Fintool can predict Ultragenyx Pharmaceutical logo RARE's earnings beat/miss a week before the call

Let Fintool AI Agent track Mitchell for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free